What PSP Corporation does

PSP Corporation is a Tokyo-headquartered medical imaging information services provider and consolidated subsidiary of TechMatrix Corporation (TSE Prime: 3762). Founded in 1989 and operating through approximately 400 employees, PSP holds over 22% of Japan's PACS market by operating facilities, serving roughly 2,500 medical institutions ranging from large university hospitals (400+ beds) to small local clinics and health screening centers. PSP runs the NOBORI cloud PACS platform — launched in 2012 as Japan's first cloud-based medical image management service — across 1,400+ facilities with proprietary NOBORI-CUBE edge appliances and dual East/West Japan data centers storing 497+ million examinations and 73+ million patient IDs.

The company's product portfolio centers on three pillars: the NOBORI cloud PACS and its Smart-Retrieve pre-fetching technology; the NOBORI PAL service platform aggregating AI diagnostic support, 3D analysis, regional medical collaboration (TONARI), emergency external image reference (TSUNAGU), radiation dose management (MINCADI), teleradiology, and digital pathology; and the NOBORI PHR patient-facing app integrated with Japan's Myna Portal government health data. AI capabilities span an in-house NOBORI Report AI assist function and a co-developed lung cancer screening model with Preferred Networks, complemented by third-party AI partners including Canon Medical, Elpixcel (EIRL), VUNO, Riverain, and Splink. The platform holds ISO 27001, ISO 27017, FISC, DICOM, and IHE certifications and processes approximately 3 million AI operations annually.

PSP generates revenue predominantly through recurring monthly subscriptions for cloud PACS services bundled with NOBORI-CUBE rental hardware (zero initial investment model), supplemented by perpetual standalone software licenses, professional implementation services, and additional subscription/per-use charges for AI and PAL add-ons. The company sells primarily through direct regional field sales teams across Japan, supplemented by a NOBORI Partner reseller program and integration distribution through Canon Medical Systems and M3AI. Strategic recent moves include the 2022 merger with NOBORI Ltd., the June 2024 acquisition of imaging CRO Regulus Inc., the October 2024 launch of NOBORI for Pathology, and the February 2026 announced ¥2.3 billion majority acquisition of digital pathology AI company Medomain Inc. International operations are conducted through PSP ASIA CO., LTD. in Bangkok, Thailand.

Name

PSP Corporation

Legal name

PSP株式会社 (PSP Corporation)

Website

https://psp.co.jp

Company type

Private

Founded year

1989

Operating status

Operating

Short description

PSP Corporation is a Tokyo-based healthcare IT subsidiary of TechMatrix Corporation providing Japan's cloud-based NOBORI PACS platform, AI diagnostic support marketplace, and NOBORI PHR patient app to approximately 2,500 medical institutions nationwide, holding over 22% domestic PACS market share.

Ownership category

akta.pro rank

Product category

Medical Imaging Software

NAICS

Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518)

SIC

Services-Computer Processing & Data Preparation (7374)

akta.pro primary industry

Picture Archiving & Communication Systems (PACS) (HLACALAA)

akta.pro secondary industries

Imaging Interoperability & Standards Enablement (DICOM/HL7/FHIR/IHE) (HLACALAJ), Radiology Reporting, Dictation & Structured Reporting (HLACALAF), Teleradiology Platforms & Reading Workflow (HLACALAK), Imaging & Diagnostic Interoperability (DICOM exchange, image sharing, VNA connectivity) (HLACABAM), Image Exchange, Sharing & Patient/Provider Portals (DICOM/Web) (HLACALAI)

Keywords

• Medical imaging software
• Cloud PACS platform
• Healthcare IT services
• Radiology information systems
• Personal health records

Headquarters

HQ city

Tokio

HQ country

Japan

HQ region

Asia

Offices13 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Infrastructure, Operations, Marketing or Sales

Revenue model

1. Cloud PACS Subscription (NOBORI): Monthly usage-based subscription model for cloud PACS services. NOBORI-CUBE provided as rental equipment with no initial investment required. Monthly fees cover software licenses, data center storage, maintenance, and support.
2. Standalone Software Licenses: One-time or perpetual license sales for standalone viewer software (EV Insite series), mammography viewers, and on-premises PACS applications.
3. Professional Services: Implementation, system integration, customization, and training services for PACS, RIS, and related systems deployment at medical institutions.
4. Hardware Sales (NOBORI-CUBE): Rental and sale of NOBORI-CUBE proprietary hardware appliances deployed at customer sites as the edge computing component of the cloud PACS system.
5. NOBORI PAL Service Platform: Additional cloud services on the PAL platform including AI diagnostic support, regional medical collaboration (TONARI), emergency external image reference (TSUNAGU), radiation dose management (MINCADI), and telepathology. May include per-use or subscription billing.
6. PHR App (NOBORI PHR): Patient-facing Personal Health Record app provided to patients of partner medical institutions. Revenue generated through institutional subscriptions from hospitals and clinics offering the service to patients.

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels6 records

Core offering

PSP Corporation develops, operates, and sells NOBORI, a cloud-based medical image management platform (PACS) that enables hospitals and clinics to store, view, and share medical images and diagnostic reports via cloud data centers with proprietary NOBORI-CUBE edge appliances deployed on customer sites. The integrated product ecosystem extends to AI-powered diagnostic support services on the NOBORI PAL platform, radiology reporting and information systems, regional medical collaboration tools, a patient-facing Personal Health Record smartphone app (NOBORI PHR), and a digital pathology PACS solution, with subscription-based monthly billing and rental hardware for zero initial investment.

Product overview

PSP Corporation offers a comprehensive medical information infrastructure with NOBORI cloud PACS as the core platform. The product portfolio includes cloud-based PACS (NOBORI), service platform (NOBORI PAL) aggregating third-party AI and specialized services, patient-facing PHR app (NOBORI PHR), radiology applications (Viewer, Report, RIS, Treatment RIS, Integrated Examination Information), regional collaboration tools (TONARI, TSUNAGU), and radiation dose management (MINCADI). Following the 2022 merger with NOBORI Ltd., the company integrated legacy on-premises products (EV Insite series) into the cloud platform and expanded into pathology PACS (NOBORI for Pathology) via Medomain partnership. The AI diagnostic support ecosystem (NOBORI PAL AI) offers multiple AI services including EIRL, VUNO Med, ClearRead, Stroke Package, and bone analysis tools. Current launches include Kyoto lung cancer screening AI (2026), PERICAN perioperative management app, and digital health examination delivery services.

Differentiator

Problem solved

Functional benefit

Brands

• NOBORI: Cloud-based medical image management system (PACS) platform providing storage, viewing, sharing, and utilization of medical images and data.
• NOBORI PAL
• NOBORI PHR
• NOBORI for Pathology
• NOBORI Viewer
• NOBORI Report
• NOBORI PAL AI
• TONARI
• TSUNAGU
• MINCADI
• 医知悟

Products and services

• NOBORI Cloud PACS Cloud-based Picture Archiving and Communication System (PACS) providing secure medical image storage and management via data centers in East and West Japan. Features Smart-Retrieve pre-fetching technology and zero initial investment through NOBORI-CUBE appliance rental model, serving hospitals and clinics.
• NOBORI PAL Service Platform

Quantifiable outcome

• 22%+ PACS market share in Japan with approximately 2,500 facilities
• +4 more outcomes

Named customers10 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration21 records

AI capability18 records

Feature8 records

Partnerships

13 partnerships are on record, tiered core and flagship.

• Preferred Networks, Inc. (株式会社Preferred Networks)coreStrategic or Co-development Partner · 8 June 2026Preferred Networks, Canon Medical Systems, and PSP co-developed an AI-powered chest X-ray diagnostic support program for Kyoto Prefecture lung cancer screening. PFN developed the AI model using normal case-dominant training data. PSP obtained medical device certification for the program. The system displays 'No Findings' for low-suspicion cases to support radiologist workflow in prefecture-wide lung cancer screening.
• Kyoto Medical Association (的一般社團法人京都府医師会)coreStrategic or Co-development Partner · 8 June 2026Kyoto Medical Association coordinates lung cancer screening diagnostic services across Kyoto Prefecture. PSP and PFN's AI chest X-ray diagnostic support program is being deployed for prefecture-wide lung cancer screening under the association's coordination. The program supports radiologist workload management and quality standardization for aging radiologist workforce in the prefecture.
• Kyoto PrefecturecoreStrategic or Co-development Partner · 8 June 2026Kyoto Prefecture is implementing AI-assisted chest X-ray diagnostic support for its public lung cancer screening program in 2026, covering multiple municipalities. This represents one of the first large-scale government deployments of AI diagnostic support in Japan's public health screening system.
• Medomain Co., Ltd. (メドメイン株式会社)flagshipStrategic or Co-development Partner · 17 February 2026Medomain is a digital pathology AI company. PSP and parent company TechMatrix acquired majority stake (70%+ equity) in Medomain for approximately 2.3 billion yen. Medomain provides PidPort digital pathology AI cloud system and WSI digital pathology imaging services. PSP integrates Medomain's pathology AI technology into its cloud NOBORI platform. Strategic focus on digital pathology platform development, FDA-equivalent medical device approval processes, and national pathology network expansion across PSP's 2,600+ facility customer base.
• Regulus Inc. (レギュラス株式会社)flagshipStrategic or Co-development Partner · 24 July 2024Regulus is an imaging CRO (Contract Research Organization) specializing in medical imaging for clinical trials and drug development. PSP acquired 100% of Regulus shares in June 2024 for clinical research, trial, and drug development using medical imaging (radiology, endoscopy, pathology). Regulus brings expertise in medical imaging clinical trial design and regulatory submission. The acquisition strengthens PSP's pathology business and PHR service for ePRO (electronic Patient Reported Outcomes) in clinical trials.
• Life Data Initiative ( Lif Data Initiative / 一般社團法人ライフデータイニシアティブ)coreStrategic or Co-development Partner · 7 June 2024LDI is a certified anonymized medical information processing organization under Japan's Next Generation Medical Infrastructure Act. PSP provides medical imaging data (X-ray, CT, MRI, etc.) collected from medical institutions to LDI for anonymization and provision to medical device developers and pharmaceutical researchers. First instance of medical imaging data provision under Japan's Next Generation Medical Infrastructure Act.
• NTT DATA Corporation (株式会社NTTデータ)coreStrategic or Co-development Partner · 7 June 2024NTT DATA is a certified medical information handling contractor under Japan's Next Generation Medical Infrastructure Act. Partnered with LDI and PSP to provide anonymized medical imaging data for program medical device development and pharmaceutical research. NTT DATA handles the technical anonymization processing including facial reconstruction prevention from CT/MRI 3D reconstruction.
• Canon Medical Systems Corporation (キヤノンメディカルシステムズ株式会社)coreTechnology or Integration · 4 April 2024Canon Medical Systems and PSP have mutual supply agreement for healthcare IT solutions. PSP distributes Canon Medical's DICOM viewer software (EV Insite R) and cloud PACS (NOBORI). Canon Medical distributes PSP's DICOM viewer software and NOBORI through their sales network. Additionally, Canon Medical's AI analysis technology and 3D processing technology are integrated into PSP's DICOM viewer. Joint AI platform collaboration includes Canon Medical Stroke basic package and other AI diagnostic solutions through the NOBORI PAL AI platform.
• M3AI Corporation (エムスリーAI株式会社)coreTechnology or Integration · 4 April 2024M3AI provides the AI platform infrastructure for NOBORI PAL AI, enabling multiple medical AI solutions (chest X-ray, brain imaging, temporal subtraction) to run on PSP's cloud PACS platform. PSP and M3AI jointly operate the AI diagnostic support platform, with M3AI distributing PSP's AI services through Canon Medical Systems sales network. Also co-founded joint venture for AI medical device development as part of the 2022 NOBORI merger.
• Splink Inc. (株式会社Splink)coreTechnology or IntegrationSplink provides Brain Life Imaging AI program for brain MRI analysis measuring hippocampal volume. Through the Brain Healthcare Program joint initiative with Millenia and PSP, Splink's AI brain imaging is integrated with cognitive function testing and NOBORI PHR for comprehensive brain health management.
• Millenia Corporation (株式会社ミレニア)coreTechnology or IntegrationMillenia provides Atama no Kenko Checkke cognitive function assessment scale with 2 million+ test records. Partnership enables integration of cognitive function data into NOBORI PHR app, allowing users to view cognitive health data alongside other medical records. Both Splink brain imaging AI and Millenia cognitive testing are linked through NOBORI PHR in the Brain Healthcare Program.
• ToYo Teknika Co., Ltd. (株式会社東陽テクニカ)coreTechnology or IntegrationToYo Teknika distributes ClearRead chest X-ray bone suppression and temporal subtraction software integrated with PSP's PACS (EV Insite net and NOBORI). Also distributes mediCAD orthopedic digital planning tool and ClearRead CT-VS lung vascular processing system through PSP's sales network.
• Abbott Diagnostics Medical K.K. (アボット ダイアグノスティクス -medical株式会社)coreTechnology or IntegrationAbbott provides Afinion 2 POC biochemistry analyzer used in pharmacy-based specimen measurement rooms across Japan. NOBORI PHR app integrates with Abbott's devices via QR code to enable patients to upload blood test results (HbA1c, cholesterol, triglycerides) directly to their personal health records.

Scale indicators10 records

Recent moves7 records

Expansion highlights7 records

Broad incumbents

• Canon Medical Systems: Canon Medical Systems is both a partner and competitor — it distributes PSP's NOBORI cloud PACS and DICOM viewer through its sales network, while also developing its own imaging AI and Abierto reading support platform. As Japan's major imaging equipment vendor, it controls the modality-side customer touchpoint.
• Siemens Healthineers: Siemens Healthineers offers the teamplay imaging platform and PACS solutions with AI diagnostic capabilities, competing with PSP for large hospital and integrated delivery network customers. Its AI-Rad Companion AI diagnostic suite is directly comparable to NOBORI PAL AI.
• GE HealthCare: GE HealthCare provides enterprise PACS, imaging AI, and digital health solutions globally with a presence in Japan via direct sales and partnerships. It competes with PSP at large hospital sites and offers cloud-based imaging archive solutions that overlap with NOBORI's value proposition.
• Agfa HealthCare: Agfa HealthCare provides enterprise imaging PACS, radiology, and AI integration solutions with a global installed base. Its Enterprise Imaging platform is a direct alternative to PSP's NOBORI offering for hospital systems.
• Fujifilm Healthcare: Fujifilm operates one of Japan's largest medical imaging IT and PACS businesses through its Healthcare division, directly competing with PSP across on-premises and cloud PACS deployments in Japanese hospitals. It is a broad incumbent with overlapping cloud PACS, RIS, and imaging AI capabilities.
• Philips Healthcare: Philips provides enterprise imaging PACS, advanced visualization, and AI-enabled diagnostic workflows in the Japanese market. It competes with PSP for premium hospital accounts and operates its own cloud-enabled imaging platform.

Direct peers

• Ambra Health: Ambra Health (now part of Intelerad) offers cloud-based medical image management and exchange with a developer-friendly API platform, comparable to PSP's cloud PACS and image sharing services. It pursues similar modern cloud PACS positioning.
• Mach7 Technologies: Mach7 provides enterprise imaging and PACS solutions built on a vendor-neutral archive architecture, conceptually similar to PSP's cloud PACS. Targets multi-site hospital networks with shared imaging data workflows.
• Sectra: Sectra is a Swedish-based enterprise imaging and PACS vendor with cloud-native and subscription offerings, directly comparable to PSP's NOBORI model. It targets large hospitals and regions with shared imaging infrastructure, similar to PSP's regional medical collaboration thesis.
• Intelerad Medical Systems: Intelerad is a cloud-native enterprise imaging and PACS platform serving hospitals and radiology practices, with a similar subscription model to PSP's NOBORI. It competes in the same category of cloud PACS deployments and growing AI marketplace.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PSP Corporation